Diana Sinclair is an accomplished biotech professional with 20 years of experience in cGMP-regulated environments, specializing in Quality Control Stability and Project Management. Positioning as the Associate Director of Quality Control at PepGen, Diana is recognized for expertise in managing comprehensive GMP stability programs and fostering cross-functional collaboration. Diana has successfully led the launch of multiple new drugs, resulting in FDA approvals, and aims to leverage extensive experience in GMP stability study design and regulatory submissions to drive impactful results within dynamic organizations. Previously, Diana has held senior roles at Takeda Oncology, Seres Therapeutics, and Shire, among others.
This person is not in the org chart
This person is not in any teams
This person is not in any offices